The initial public offering (IPO) of Vadodara-based Sudeep Pharma will open for subscription on November 21 and conclude on November 25. The company aims to raise ₹895 crore through the issue, which includes a mix of fresh issue and offer-for-sale (OFS) components.

Ahead of the issue launch, Sudeep Pharma mopped up ₹268.5 crore from anchor investors.

Mutual funds such as SBI, ICICI Prudential, HDFC, Axis, Nippon, Aditya Birla, and Bandhan participated in the anchor round. Other marquee investors, including Mukul Agarwal (Param Capital Sanshi Fund–I) and Manoj Garg (WhiteOak), also built positions. Prashant Jain (3P Investment) is part of the anchor book as well.

Sudeep Pharma has fixed the price band at ₹563-593 per equity share, valuing the company close to ₹6,700 crore at the higher e

See Full Page